HomeKRYS • NASDAQ
add
Krystal Biotech Inc
Previous close
$182.29
Day range
$182.02 - $191.27
Year range
$99.14 - $219.34
Market cap
5.48B USD
Avg Volume
227.78K
P/E ratio
107.73
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 83.84M | 879.91% |
Operating expense | 42.22M | 23.01% |
Net income | 27.18M | -66.34% |
Net profit margin | 32.42 | -96.56% |
Earnings per share | 1.29 | 293.67% |
EBITDA | 35.27M | 239.70% |
Effective tax rate | 8.70% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 588.32M | 4.67% |
Total assets | 982.32M | 24.29% |
Total liabilities | 96.47M | 180.43% |
Total equity | 885.85M | — |
Shares outstanding | 28.76M | — |
Price to book | 5.92 | — |
Return on assets | 9.19% | — |
Return on capital | 10.04% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 27.18M | -66.34% |
Cash from operations | 58.86M | 377.29% |
Cash from investing | -34.33M | -132.63% |
Cash from financing | 3.36M | -74.87% |
Net change in cash | 28.18M | -71.06% |
Free cash flow | 50.70M | 372.54% |
About
Founded
2015
Headquarters
Website
Employees
229
